Visioneering Technologies, Inc. Announces Brian Atkinson as Territory Manager for the Dallas/Ft. Worth Market
Atlanta, GA (December 21, 2016) – Visioneering Technologies, Inc. (VTI), announced that Brian Atkinson has joined their sales organization as Territory Manager. Atkinson will be responsible for introducing the unique, patented technology of the NaturalVue® (etafilcon A) Multifocal Contact Lenses and other NaturalVue® Brand products to greater Dallas/Ft. Worth area.
“Brian brings an energy to the VTI team that is fun to see,” said Tony Sommer, Senior Vice-President, Sales & Marketing for VTI. “His natural approach to his job makes his customers comfortable immediately. As a lifelong resident of the DFW area, and with over 5 years’ experience in the industry, I am sure that Brian will contribute to VTI’s growth in Texas in a big way.”
Atkinson brings solid sales experience in the eyecare industry with such companies as Transition Optical and Essilor of America. A graduate of the University of North Texas, Brian has a BS in Kinesiology. Said Atkinson, “I am so excited to be a part of the VTI family as I get to help redefine vision through advanced engineering and commitment to excellence everyday while supporting private practice exclusively.”
Brian may be reached at email@example.com or 1-844-VTI-LENS (1-844-884-5367), ext. 118.
About Visioneering Technologies, Inc.
Visioneering Technologies, Inc. (VTI), headquartered in northern Atlanta, Georgia, is an innovative company dedicated to developing products that improve vision. With a portfolio of technologies, the company uses creative and differentiated design approaches to develop products that enhance practitioner and patient experiences. VTI optical designs have been awarded nine patents worldwide, and an additional ten patents are pending. Strength in science, an entrepreneurial culture, and the ability to bring technology to life make Visioneering Technologies, Inc. a company to watch. For more information, visit www.vtivision.com/ or call 844-884-5367, ext. 104.